Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.

van den Ende RPJ, Kerkhof EM, Rigter LS, van Leerdam ME, Peters FP, van Triest B, Staring M, Marijnen CAM, van der Heide UA.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1151-1159. doi: 10.1016/j.ijrobp.2019.08.052. Epub 2019 Aug 30.

2.

Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer.

Walterbos NR, Fiocco M, Neelis KJ, van der Linden YM, Langers AMJ, Slingerland M, de Steur WO, Peters FP, Lips IM.

Clin Transl Radiat Oncol. 2019 Apr 24;17:24-31. doi: 10.1016/j.ctro.2019.04.017. eCollection 2019 Jul.

3.

Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers.

Lunenburg CATC, Henricks LM, Dreussi E, Peters FP, Fiocco M, Meulendijks D, Toffoli G, Guchelaar HJ, Swen JJ, Cecchin E, Schellens JHM, Gelderblom H.

Eur J Cancer. 2018 Nov;104:210-218. doi: 10.1016/j.ejca.2018.07.138. Epub 2018 Oct 23.

PMID:
30361102
4.

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.

Slagter AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, van Grieken NCT, Sikorska K, Cats A, Muller-Timmermans P, Hulshof MCCM, Boot H, Los M, Beerepoot LV, Peters FPJ, Hospers GAP, van Etten B, Hartgrink HH, van Berge Henegouwen MI, Nieuwenhuijzen GAP, van Hillegersberg R, van der Peet DL, Grabsch HI, Verheij M.

BMC Cancer. 2018 Sep 10;18(1):877. doi: 10.1186/s12885-018-4770-2.

5.

Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.

Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, Bhangu A, Garm Spindler KL, Gray R, Handley K, Kaur M, Kerkhof E, Kronborg CJ, Magill L, Marijnen CAM, Nagtegaal ID, Nyvang L, Peters FP, Pfeiffer P, Punt C, Quirke P, Sebag-Montefiore D, Teo M, West N, de Wilt JHW; for STAR-TREC Collaborative Group.

BMJ Open. 2017 Dec 28;7(12):e019474. doi: 10.1136/bmjopen-2017-019474.

6.

Ruthenium-106 brachytherapy for iris and iridociliary melanomas.

Marinkovic M, Horeweg N, Laman MS, Bleeker JC, Ketelaars M, Peters FP, Luyten GPM, Creutzberg CL.

Br J Ophthalmol. 2018 Aug;102(8):1154-1159. doi: 10.1136/bjophthalmol-2017-310688. Epub 2017 Nov 9.

PMID:
29122824
7.

[A male with intra-abdominal nodules on a CT scan].

Smeets FGM, Peters FPJ.

Ned Tijdschr Geneeskd. 2017;161:D1503. Dutch.

PMID:
29027514
8.

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.

Aarts MJ, Vriens BE, de Boer M, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Tol J, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, van der Rijt CCD, Smilde TJ, van der Velden AW, Peer N, Tjan-Heijnen VCG.

Oncology. 2017;93(5):323-328. doi: 10.1159/000479067. Epub 2017 Aug 22.

PMID:
28848182
9.

Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry.

Westgeest HM, Uyl-de Groot CA, van Moorselaar RJA, de Wit R, van den Bergh ACM, Coenen JLLM, Beerlage HP, Hendriks MP, Bos MMEM, van den Berg P, van de Wouw AJ, Spermon R, Boerma MO, Geenen MM, Tick LW, Polee MB, Bloemendal HJ, Cordia I, Peters FPJ, de Vos AI, van den Bosch J, van den Eertwegh AJM, Gerritsen WR.

Eur Urol Focus. 2018 Sep;4(5):694-701. doi: 10.1016/j.euf.2016.09.008. Epub 2016 Oct 13.

PMID:
28753794
10.

Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.

van Ruler MA, Peters FP, Slingerland M, Fiocco M, Grootenboers DA, Vulink AJ, Marijnen CA, Neelis KJ.

Dis Esophagus. 2017 Apr 1;30(4):1-9. doi: 10.1093/dote/dow033.

PMID:
28375477
11.

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium.

van Kampen RJW, Ramaekers BLT, Lobbezoo DJA, de Boer M, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FPJ, van Riel JMG, Peters NAJB, Tjan-Heijnen VCG, Joore MA.

Eur J Cancer. 2017 Jul;79:238-246. doi: 10.1016/j.ejca.2017.01.027. Epub 2017 Feb 27.

PMID:
28245951
12.

Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial.

Cirkel GA, Hamberg P, Sleijfer S, Loosveld OJL, Dercksen MW, Los M, Polee MB, van den Berkmortel F, Aarts MJ, Beerepoot LV, Groenewegen G, Lolkema MP, Tascilar M, Portielje JEA, Peters FPJ, Kl├╝mpen HJ, van der Noort V, Haanen JBAG, Voest EE; Dutch WIN-O Consortium.

JAMA Oncol. 2017 Apr 1;3(4):501-508. doi: 10.1001/jamaoncol.2016.5202.

PMID:
27918762
13.

Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.

Marinkovic M, Horeweg N, Fiocco M, Peters FP, Sommers LW, Laman MS, Bleeker JC, Ketelaars M, Luyten GP, Creutzberg CL.

Eur J Cancer. 2016 Nov;68:106-113. doi: 10.1016/j.ejca.2016.09.009. Epub 2016 Oct 12.

PMID:
27741435
14.

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.

Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Peer PG, Tjan-Heijnen VC.

Ann Oncol. 2016 Feb;27(2):256-62. doi: 10.1093/annonc/mdv544. Epub 2015 Nov 16.

PMID:
26578730
15.

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Peer PG, Tjan-Heijnen VC.

Br J Cancer. 2015 Apr 28;112(9):1445-51. doi: 10.1038/bjc.2015.127. Epub 2015 Apr 16.

16.

Duodenal perforation following bile duct endoprosthesis placement.

Kusters PJ, Keulen ET, Peters FP.

Endoscopy. 2014;46 Suppl 1 UCTN:E646-7. doi: 10.1055/s-0034-1390849. Epub 2014 Dec 19. No abstract available.

PMID:
25526406
17.

A lung cancer patient with painful fingers.

Scholtes BM, Erdkamp FL, Peters FP.

Neth J Med. 2014 Oct;72(8):431, 435. No abstract available.

18.

Longitudinal changes and seasonal variations in serum 25-hydroxyvitamin D levels in different age groups: results of the Longitudinal Aging Study Amsterdam.

van Schoor NM, Knol DL, Deeg DJ, Peters FP, Heijboer AC, Lips P.

Osteoporos Int. 2014 May;25(5):1483-91. doi: 10.1007/s00198-014-2651-3. Epub 2014 Feb 26.

PMID:
24570295
19.

Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.

Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Joore MA, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4283-9. doi: 10.1200/JCO.2012.48.3644. Epub 2013 Oct 28.

PMID:
24166522
20.

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.

Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Borm GF, Tjan-Heijnen VC.

Breast Cancer Res Treat. 2013 Oct;141(3):507-14. doi: 10.1007/s10549-013-2711-y. Epub 2013 Oct 9.

PMID:
24104881
21.

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4290-6. doi: 10.1200/JCO.2012.44.6229. Epub 2013 Apr 29.

PMID:
23630211
22.

Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program.

van Vilsteren FG, Pouw RE, Herrero LA, Peters FP, Bisschops R, Houben M, Peters FT, Schenk BE, Weusten BL, Visser M, Ten Kate FJ, Fockens P, Schoon EJ, Bergman JJ.

Endoscopy. 2012 Jan;44(1):4-12. doi: 10.1055/s-0031-1291384. Epub 2011 Nov 22.

PMID:
22109651
23.

Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia.

Pouw RE, van Vilsteren FG, Peters FP, Alvarez Herrero L, Ten Kate FJ, Visser M, Schenk BE, Schoon EJ, Peters FT, Houben M, Bisschops R, Weusten BL, Bergman JJ.

Gastrointest Endosc. 2011 Jul;74(1):35-43. doi: 10.1016/j.gie.2011.03.1243.

PMID:
21704807
24.

[Haemorrhages due to vitamin C deficiency. Scurvy in the 21st century].

Michiels M, Mellema M, Peters FP.

Ned Tijdschr Geneeskd. 2010;154:A1638. Dutch.

PMID:
20699018
25.

Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.

Pouw RE, Peters FP, Sempoux C, Piessevaux H, Deprez PH.

Endoscopy. 2008 Nov;40(11):892-8. doi: 10.1055/s-2008-1077675. Epub 2008 Nov 13.

PMID:
19009481
26.

Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports.

Curvers WL, Peters FP, Elzer B, Schaap AJ, Baak LC, van Oijen A, Mallant-Hent RM, Ten Kate F, Krishnadath KK, Bergman JJ.

Eur J Gastroenterol Hepatol. 2008 Jul;20(7):601-7. doi: 10.1097/MEG.0b013e3282f8295d.

PMID:
18679060
27.

Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.

Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, Ten Kate F, Fockens P, Bergman JJ.

Endoscopy. 2008 May;40(5):370-9.

PMID:
18494132
28.

Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.

Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, Krishnadath KK, Ten Kate F, Fockens P, Bergman JJ.

Endoscopy. 2008 May;40(5):359-69.

PMID:
18494131
29.

Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error.

Peters FP, Curvers WL, Rosmolen WD, de Vries CE, Ten Kate FJ, Krishnadath KK, Fockens P, Bergman JJ.

Dis Esophagus. 2008;21(6):475-9. doi: 10.1111/j.1442-2050.2008.00813.x. Epub 2008 Apr 22.

PMID:
18430186
30.

[Influenza in children undergoing chemotherapy].

Peters FP.

Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2697; author reply 2697. Dutch. No abstract available.

PMID:
18179090
31.

Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus.

Peters FP, Brakenhoff KP, Curvers WL, Rosmolen WD, Fockens P, ten Kate FJ, Krishnadath KK, Bergman JJ.

Gastrointest Endosc. 2008 Apr;67(4):604-9. Epub 2007 Dec 26.

PMID:
18155214
32.

Endoscopic cap resection for treatment of early Barrett's neoplasia is safe: a prospective analysis of acute and early complications in 216 procedures.

Peters FP, Brakenhoff KP, Curvers WL, Rosmolen WD, ten Kate FJ, Krishnadath KK, Fockens P, Bergman JJ.

Dis Esophagus. 2007;20(6):510-5.

PMID:
17958727
33.

Thorium dioxide-related haemangiosarcoma of the liver.

van Kampen RJ, Erdkamp FL, Peters FP.

Neth J Med. 2007 Sep;65(8):279-82. Review.

34.

Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.

Peters FP, Krishnadath KK, Rygiel AM, Curvers WL, Rosmolen WD, Fockens P, Ten Kate FJ, van Baal JW, Bergman JJ.

Am J Gastroenterol. 2007 Sep;102(9):1853-61. Epub 2007 May 17.

PMID:
17509033
35.

Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls.

Peters FP, Kara MA, Curvers WL, Rosmolen WD, Fockens P, Krishnadath KK, Ten Kate FJ, Bergman JJ.

Eur J Gastroenterol Hepatol. 2007 Apr;19(4):311-5.

PMID:
17353695
36.

Sclerosing peritonitis: an unusual cause of ascites in a patient with systemic lupus erythematosus.

Pepels MJ, Peters FP, Mebis JJ, Ceelen TL, Hoofwijk AG, Erdkamp FL.

Neth J Med. 2006 Oct;64(9):346-9.

37.

Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study.

Peters FP, Kara MA, Rosmolen WD, ten Kate FJ, Krishnadath KK, van Lanschot JJ, Fockens P, Bergman JJ.

Am J Gastroenterol. 2006 Jul;101(7):1449-57.

PMID:
16863545
38.

Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus.

Kara MA, Peters FP, Fockens P, ten Kate FJ, Bergman JJ.

Gastrointest Endosc. 2006 Aug;64(2):176-85.

PMID:
16860064
39.

[Serious intoxication after inhaling methanol].

van Kampen RJ, Krekels MM, Derijks HJ, Peters FP.

Ned Tijdschr Geneeskd. 2006 Jun 10;150(23):1298-302. Dutch.

PMID:
16821455
40.

[The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001].

Peters FP, Erdkamp FL.

Ned Tijdschr Geneeskd. 2005 Oct 1;149(40):2254-5. Dutch. No abstract available.

PMID:
16235806
41.

High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study.

Kara MA, Peters FP, Rosmolen WD, Krishnadath KK, ten Kate FJ, Fockens P, Bergman JJ.

Endoscopy. 2005 Oct;37(10):929-36.

PMID:
16189764
42.

Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus.

Kara MA, Peters FP, Ten Kate FJ, Van Deventer SJ, Fockens P, Bergman JJ.

Gastrointest Endosc. 2005 May;61(6):679-85.

PMID:
15855971
43.

Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus.

Peters FP, Kara MA, Rosmolen WD, Aalders MC, Ten Kate FJ, Bultje BC, Krishnadath KK, Fockens P, van Lanschot JJ, van Deventer SJ, Bergman JJ.

Gastrointest Endosc. 2005 Apr;61(4):506-14.

PMID:
15812401
44.

[Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].

Keulen ET, Mebis J, Erdkamp FL, Peters FP.

Ned Tijdschr Geneeskd. 2003 Oct 25;147(43):2145. Dutch. No abstract available.

PMID:
14619208
45.

Reversible migratory osteoporosis in renal oncocytoma mimicking renal cell carcinoma with bone metastases.

Peters FP, Verhoeven MA, Anten HW, Erdkamp FL, van der Pol H.

Neth J Med. 2002 Nov;60(10):411-3.

46.

[Pulmonary problems associated with lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)].

Peters FP, Erdkamp FL.

Ned Tijdschr Geneeskd. 2002 Aug 31;146(35):1664. Dutch. No abstract available.

PMID:
12233165
47.

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.

Peters FP, Fickers MM, Erdkamp FL, Wals J, Wils JA, Schouten HC.

Ann Hematol. 2001 Jul;80(7):406-10.

PMID:
11529466
48.

Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.

Peters FP, Lalisang RI, Fickers MM, Erdkamp FL, Wils JA, Houben SG, Wals J, Schouten HC.

Ann Hematol. 2001 Mar;80(3):155-9.

PMID:
11320900
49.

Anderson-Fabry's disease: alpha-galactosidase deficiency.

Peters FP, Vermeulen A, Kho TL.

Lancet. 2001 Jan 13;357(9250):138-40. No abstract available.

PMID:
11197415
50.

[Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice].

Peters FP, Erdkamp FL.

Ned Tijdschr Geneeskd. 2000 Sep 2;144(36):1752-3. Dutch. No abstract available.

PMID:
10992902

Supplemental Content

Loading ...
Support Center